iSpecimen Inc.
ISPC
$5.62
$0.397.46%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -51.41% | -85.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -51.41% | -85.05% | |||
| Cost of Revenue | 192.67% | -53.94% | |||
| Gross Profit | -458.27% | -136.43% | |||
| SG&A Expenses | -26.01% | 40.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.71% | 15.87% | |||
| Operating Income | 5.03% | -55.39% | |||
| Income Before Tax | -79.86% | -165.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -79.86% | -165.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -79.86% | -165.53% | |||
| EBIT | 5.03% | -55.39% | |||
| EBITDA | 5.15% | -57.44% | |||
| EPS Basic | -36.18% | -13.54% | |||
| Normalized Basic EPS | -36.19% | -13.54% | |||
| EPS Diluted | -36.18% | -13.54% | |||
| Normalized Diluted EPS | -36.19% | -13.54% | |||
| Average Basic Shares Outstanding | 32.06% | 133.87% | |||
| Average Diluted Shares Outstanding | 32.06% | 133.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||